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Conspectus
RNA owes its role as the central conduit for gene expression to its ability to encode
information at two levels: in its linear sequence and in its ability to fold back on itself to
form complex higher-order structures. Understanding the global structure-function
interrelationships mediated by RNA remains a great challenge in molecular and structural
biology. We describe evolving work in our laboratory focused creating facile, generic,
quantitative, accurate, and highly informative approaches for understanding RNA structure
at nucleotide resolution for RNAs of wide ranges of size s and complexities in biological
environments.
The core innovation derives from our discovery that the nucleophilic reactivity of the ribose
2′-hydroxyl in RNA is gated by local nucleotide flexibility. The 2′-hydroxyl is reactive at
conformationally flexible positions but is unreactive at nucleotides constrained by base
pairing. Sites of modification in RNA can be efficiently detected using either primer
extension or protection from exoribonucleolytic degradation. This technology is now called
SHAPE, for selective 2′-hydroxyl acylation analyzed by primer extension (or protection
from exoribonuclease). SHAPE reactivities are largely independent of nucleotide identity
but correlate closely with model-free measurements of molecular order. The simple SHAPE
reaction is thus a robust, nucleotide-resolution, biophysical measurement of RNA structure.
SHAPE can be used to provide an experimental correction to RNA folding algorithms and,
in favorable cases, yield kilobase-scale secondary structure predictions with high accuracies.
SHAPE chemistry is based on very simple reactive carbonyl centers that can be varied to
yield slow- and fast-reacting reagents. Differential SHAPE reactivities can be used to detect
specific RNA positions with slow local nucleotide dynamics. These positions, which are
often in the C2′-endo conformation, have the potential to function as molecular timers that
regulate RNA folding and function. In addition, fast-reacting SHAPE reagents can be used
to visualize RNA structural biogenesis and RNA-protein assembly reactions in 1 second
snapshots via very straightforward experiments.
Application of SHAPE to challenging problems in biology has revealed surprises in well-
studied systems and has indentified new regions likely to have critical functional roles based
on their high levels of RNA structure. For example, SHAPE analysis of large RNAs like
authentic viral RNA genomes suggests that RNA structure organizes regulatory motifs and
regulates splicing, protein folding, genome recombination, and ribonucleoprotein assembly.
SHAPE has also revealed the limitations of the hierarchical model for RNA folding.
Continued development and application of SHAPE technologies will advance our
understanding of the many ways in which the genetic code is expressed through the
underlying structure of RNA.
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The central role of RNA in biology reflects its unique abilities to encode genetic information
in its linear sequence and to fold into structures that contribute to diverse biological
functions. RNA structure may selectively present or conceal access to the information stored
in a linear RNA sequence. Alternatively, the structures themselves may be important; these
structures can be as simple as the small hairpins processed to become miRNAs or as
sophisticated as ligand binding switches, complex protein binding elements, and catalytic
active sites.
The structure of an individual RNA is determined by the complex pattern of interactions
among nucleotide bases at both secondary and tertiary structure levels. The secondary
structure consists of base-pairing interactions that form helices and define loops in
individual structural elements. Tertiary interactions are longer-range and bring individual
structural elements together to create higher-order structures. There are strong hints that
transcription initiation codes1, splicing codes2,4, translation initiation codes3, and protein
folding codes4,5 are all expressed in the form of RNA structure. Thus, the raw genetic
information encoded in the primary sequence of RNA is communicated by additional
information encoded in the RNA secondary and tertiary structure.
We have only begun to glimpse these RNA codes because the structures of the vast majority
of potential regulatory and functional elements in RNA are unknown. The current situation
resembles playing on a complex jungle gym with one’s eyes closed. Experience in our
laboratory emphasizes the importance of the following principles. First, each RNA has many
possible secondary structures, but only a few are highly populated. Second, biologically
important differences between structures can be subtle. Thus, identifying populated states of
an RNA requires structural information for every nucleotide. Third, short fragments of long
RNAs often do not fully recapitulate the structure that exists in the authentic RNA.
Moreover, folding is subject to very strong “end effects” such that either omitting an
outlying element or adding flanking sequences may induce misfolding. Thus, full-length,
biologically active RNAs should be studied. Fourth, the fine details and dynamics that
contribute to RNA folding are important. Thus, sequence specificities, time dependencies,
and other idiosyncrasies of experiments designed to probe the RNA structure must be well
understood. In this review, we discuss the applications of selective 2′-hydroxyl acylation
analyzed by primer extension (SHAPE), a collection of technologies capable of measuring
local nucleotide flexibility at single-nucleotide resolution for RNAs of arbitrary size in
diverse biological environments6.
Simple, Generic, Covalent Chemistry at the RNA 2′-Hydroxyl
Our initial vision was to find a simple, generic approach to probe simultaneously the
structure of every nucleotide within an RNA6. Early work from our lab showed that
chemical reactivity at the 2′-ribose position (Figure 1A) is exquisitely sensitive to the local
nucleotide environment7–10. We discovered that a wide variety of electrophilic reagents,
especially anhydrides and acyl cyanides, react at the 2′-hydroxyl group, and that reactivities
are strongly gated by local nucleotide flexibility (Figure 1B). Flexible nucleotides sample
multiple conformations, a few of which strongly facilitate nucleophilic attack by the 2′-
hydroxyl. The reactivity of individual nucleotides is determined by electrostatic
communication between the 2′-OH and adjacent 3′-phosphate diester6,9 and other features
intrinsic to favorable ribose conformations(McGinnis and Weeks, unpublished results).
Electrophilic reagents capable of reacting with RNA 2′-hydroxyl groups also undergo
simultaneous inactivation by hydrolysis with water (Figure 1C). This competing hydrolysis
reaction imparts three advantages to SHAPE experiments. First, the hydrolysis reaction
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makes RNA probing extremely straightforward to perform. The hydroxyl-selective
electrophile either reacts with RNA or is inactivated by hydrolysis: No explicit quench step
is required. Second, although reaction with RNA is the experimental focus of SHAPE, the
solution lifetime of a given SHAPE reagent is determined primarily by reagent hydrolysis
with ~55 M water. Thus, SHAPE modification of RNA is insensitive to both the RNA
concentration and to complications due to additional cross-reacting components, including
buffer components, small molecules, or proteins. Third, as will be outlined below,
hydrolysis rates for distinct SHAPE reagents vary over a large range and by comparing
reactivities of different reagents it is possible to examine RNA folding kinetics and
dynamics in very straightforward experiments.
The Basic SHAPE Experiment
RNA structure analysis involves treatment of an RNA with a SHAPE reagent, such as
isatoic anhydride (IA), N-methyl isatoic anhydride (NMIA), 1-methyl-7-nitro-isatoic
anhydride (1M7), or benzoyl cyanide (BzCN) (Scheme 1)6,11,12. Reaction results in the
selective formation of covalent adducts at the 2′-ribose position of flexible nucleotides.
Reaction conditions are controlled to yield sparse modification of the RNA, typically
modification of 1 in 300 nucleotides. The detected signal thus reflects uncorrelated adduct-
forming events on unmodified RNA or in unmodified regions of a long RNA. The reaction
is allowed to proceed until the reagent is consumed by either reaction with RNA or by
hydrolysis with water. For the general analysis of RNA structure, the 1M7 SHAPE
reagent11(Figure 1B) is easy to handle, reacts in ~1 minute, and reports RNA secondary and
tertiary interactions accurately.
Following selective 2′-hydroxyl acylation (Figure 2A), covalent SHAPE adducts are
detected by reverse transcriptase-mediated primer extension6,13. DNA synthesis by reverse
transcriptase stops one nucleotide prior to the position of an adduct (Figure 2B)6,10. The
length of each cDNA reports the site of a SHAPE modification in the original RNA. A
control primer extension reaction is performed in parallel using unmodified RNA to locate
sites of natural reverse transcriptase pausing and pre-existing RNA degradation. Peaks in
both the modified and no-reagent control lanes are assigned by comparison with sequencing
ladders(Figure 2C). Subtraction of the intensity of modified RNA peaks from intensities of
no-reagent control peaks yields a reactivity profile (Figure 2D)13,14. Nucleotides constrained
by base-pairing and tertiary interactions have low SHAPE reactivities whereas single-
stranded and unconstrained nucleotides have higher reactivities, as illustrated for the TPP
riboswitch aptamer domain(Figure 2E).
High-throughput SHAPE can be performed using fluorescently labeled primers and capillary
electrophoresis using a commercial DNA sequencing instrument15 and analyzed using
custom software14. A single high-throughput SHAPE experiment typically provides data on
several hundred RNA nucleotides and is particularly well suited for analyzing the structure
of large RNAs15. 2′-O-adducts can also be detected by their ability to protect an RNA from
degradation by a 3′ → 5′ exoribonuclease (RNase-detected SHAPE)16. RNase-detected
SHAPE allows analysis of short RNAs and nucleotides very close to the ends of an RNA.
SHAPE as a Quantitative Measure of Nucleotide Flexibility
Our laboratory has pursued three classes of experiments to place SHAPE chemistry on a
rigorous biophysical foundation. First, analysis of nucleotide reactivity preferences for
NMIA and 1M7 shows that adenosine and guanine react approximately 1.6-fold more
rapidly than do cytosine and uridine (Figure 3A). These small, but statistically significant,
differences appear to have no effect on the ability of SHAPE to measure quantitative
conformational features at all nucleotides in an RNA. Variations in nucleotide reactivity for
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SHAPE reagents are much smaller than the biases found for other chemical probes that form
covalent adducts with RNA 17.
Second, nucleotide-resolution dynamics in RNA can be measured by NMR using the model-
free generalized order parameter, S218,19, which varies from 0.0 (fully disordered) to 1.0
(fully ordered). Nucleotides that are highly ordered have large S2 values (~0.95), whereas
nucleotides that sample a larger conformational space have much lower S2 values (~0.5) 19.
SHAPE and NMR analyses were performed on three well characterized RNAs20. Nucleotide
resolution SHAPE reactivities and the NMR-derived S2 parameter correlate strongly. For
example, for the RNA regulatory element that binds the U1A protein, r is 0.89 (Figure 3B).
This correlation is impressive given that S2 measurement are derived primarily from NMR
measurements on the picosecond to nanosecond timescale, whereas SHAPE is likely
influenced by these rapid motions and by motions on a slower time scale. From these
experiments, we conclude that SHAPE measures spatial disorder at single nucleotide
resolution.
Third, it was formally possible that SHAPE reactivity might be modulated by the physical
accessibility of the 2′-hydroxyl group. Although this group is solvent accessible in an
isolated helix, it is often buried in folded RNA structures (Figure 1A). Multiple experiments
on simple duplexes and on RNAs with complex tertiary structures have shown there is
essentially no relationship between SHAPE reactivities and solvent accessibility4,6,20–22.
Critically, many fully buried, but unconstrained, nucleotides react readily with SHAPE
reagents. SHAPE thus probes the local nucleotide flexibility of RNA nucleotides regardless
of solvent accessibility.
Accurate SHAPE-directed RNA Secondary Structure Prediction
Most computational methods predict RNA secondary structure by approximating the free
energy of structural motifs as the sum of individual base-pairing energies within these motifs
(reviewed in 23,24). This works well for simple structures, especially hairpins, but is not
accurate for large RNAs. We lack thermodynamic parameters for all possible sequence
elements, do not understand the contributions of higher-order interactions to free energy,
and cannot predict the influences of RNA folding kinetics or interactions with proteins or
small molecules. For example, when the secondary structure of the E. coli 16S rRNA is
predicted based on sequence alone using one of the most accurate programs currently
available, RNA structure25,26, only 50% of accepted base pairs are predicted correctly
(Figure 4A)27. Accuracies can be improved by incorporation of experimental information
into the prediction algorithm28. In general, data obtained from small chemical probes
improves prediction accuracy to a much greater extent than data generated by RNase
enzymes29,30. Prediction of 16S rRNA structure improves to 72% upon incorporation of
data from traditional chemical probing reagents (Figure 4B)27. However, this structure still
contains serious errors.
As outlined above, SHAPE yields a true biophysical measurement of RNA dynamics. We
thus converted SHAPE reactivities into a pseudo-free energy change term (ΔGSHAPE) and
used this as an experimental correction to an RNA folding algorithm. Using SHAPE pseudo-
free energies derived from reaction with the 1M7 reagent, the structures of 16S rRNA
(Figure 4C) and a set of smaller RNAs ranging in size from 75–155 nt are predicted with
accuracies of ~95% 27. In a few areas (Figure 4C), SHAPE analysis suggests that the 16S
rRNA may adopt alternative conformations not found in the accepted model. In general,
SHAPE-directed RNA secondary structure prediction has proven highly accurate; additional
innovations will be required to predict structures in which only a few nucleotides are
unconstrained and thus reactive11,27.
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The nucleotide-resolution data produced by SHAPE has consistently yielded structural
surprises. Before showing examples in which SHAPE supports alternative models of
secondary structure and folding, we do want to emphasize that SHAPE cannot prove that
any of the proposed RNA structures are correct. However, any proposed model must be
substantially compatible with SHAPE analyses.
The frameshift element in the HIV-1 RNA genome causes a -1 frameshift to enable the
translation of the HIV-1 Pol gene31. This element has traditionally been modeled as a simple
stem-loop downstream of a single-stranded, poly-U slippery sequence (Figure 5A). SHAPE
analysis of an intact, full-length HIV-1 genomic RNA revealed that several regions proposed
to be single stranded actually had low SHAPE reactivities (Figure 5A, red bars)4. SHAPE-
derived pseudo-free energies suggest that the slippery sequence base pairs to an upstream
sequence and the complete regulatory signal forms a large branched RNA domain (Figure
5B)4. The revised model is consistent with previous findings that the HIV-1 frameshift
element required additional sequences downstream of the simple stem-loop for full
activity32,33. Phylogenetic analysis revealed that the structure proposed based on SHAPE
data is conserved among divergent HIV-1 isolates4.
In a second example, the RNA genome of Murine Leukemia Virus (MuLV) forms a dimer
during a critical step in virion packaging. The dimer structure is minimally composed of two
palindromic sequences (PAL1 and PAL2) that form intermolecular duplexes and two stem
loops (SL1 and SL2) that form loop-loop interactions (reviewed in 34,35). SHAPE analysis
of the MuLV RNA domain using authentic genomic RNA revealed several regions in which
nucleotides proposed to base pair actually had high SHAPE reactivities (Figure 5C)35–37.
The SHAPE-directed model of the dimerization domain suggests that the PAL1 and PAL2
duplexes are significantly shorter than traditionally drawn34 and that many of the
nucleotides between PAL1 and PAL2 form a large, bulged stem-loop structure, SL0 (Figure
5D)37. Subsequent work showed that the two sets of UCUG sequences, which are exposed
and flanked by helices in the SHAPE-directed model but partially obscured in the prior
model, constitute the viral packaging signal38.
In a third example, we monitored the unfolding of tRNAAsp transcripts as a function of three
distinct perturbations: reduced Mg2+ concentration, increased temperature, and addition of
the cationic antibiotic tobramycin39,40. Although presumed to be simple, the SHAPE data
revealed that the energy landscape for the folding of this molecule contains many
structurally diverse states: Each of these three conditions denatured the tRNA in a unique
way and yielded distinct end structures (Figure 6). These studies reveal that the folding of
even a small RNA molecule can be very complex and non-hierarchical.
These three examples illustrate principles that apply broadly to the analysis of RNA
structure using SHAPE. First, many important elements of prior models remain key features
in the SHAPE-directed analysis, for example, the 1660 hairpin in HIV-131, the UCUG
elements in the dimerization domain of MuLV41, and the sensitivity of tRNAAsp structure to
ligand binding. Second, SHAPE reveals structural details that may result in revision of
accepted models. The revised structural models are substantially consistent with prior
functional data, but these data are interpreted in a different way. Third, elements within
SHAPE-directed RNA structure models sometimes do not correlate perfectly with the
SHAPE data. This reflects, in part, that multiple structures can be formed at equilibrium and
that a single model may be an over simplification37,40,42. In addition, pseudoknots and other
tertiary interactions need to be better accounted for in our algorithms.
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Analysis of RNA Dynamics using SHAPE
In aqueous solution, SHAPE reagents react with RNA and also undergo inactivation by
hydrolysis (Figure 1C). The rate of reaction with RNA is proportional to the rate of
hydrolysis. Our laboratory has created a tool kit of SHAPE reagents (Scheme 1) that makes
it possible to study the local folding dynamics of individual RNA nucleotides. There are two
general approaches for using SHAPE to obtain time-resolved information regarding RNA
folding: by differential reactivity and by using fast-reacting reagents.
When differential reactivities of slow- versus fast-reacting SHAPE reagents, such as IA
versus 1M7 (Scheme 1) are compared, most nucleotides have identical reactivities43,44.
However, a critical subset is reactive towards the slow reagent but unreactive towards the
fast reagent (Figure 7A). These nucleotides exhibit very slow local nucleotide dynamics
with half-lives on the order of minutes and many adopt the C2′-endo conformation.
Nucleotides with a C2′-endo conformation are much less prevalent than C3′-endo
nucleotides but are highly over-represented in regions of RNA molecules with complex
tertiary structures44,45. One such nucleotide is A130 in the specificity domain of the B.
subtilis RNase P ribozyme. A130 shows strong differential SHAPE reactivity, adopts the
C2′-endo conformation, and mediates a critical tertiary interaction by stacking with
nucleotide A230 (Figure 7B). These two nucleotides play a critical role in recognition of the
tRNA substrate46,47.
The time-frame of many RNA folding events is on the order of a few seconds to minutes.
Benzyl cyanide (BzCN, Scheme 1) reacts completely in 1 second and is used in time-
resolved SHAPE12,48 to take snap-shots of RNA structure (Figure 7C). Time-resolved
SHAPE showed that the tertiary folding of the RNase P domain proceeds in two distinct,
kinetically significant steps (Figure 7D)12. Local tertiary structures involving the J11/12 and
J12/11 loops fold at ~0.06 sec−1. In contrast, inter-domain tertiary interactions, like that
involving A130 and which span 55 Å, fold much more slowly (~0.004 sec−1; Figure 7E).
Strikingly, deleting A130 sped up folding of the whole domain by an order of magnitude44.
Together, differential and time-resolved SHAPE support the general model that certain C2′-
endo nucleotides function as molecular timers to control RNA folding kinetics.
RNA-Protein Interactions
SHAPE is a robust tool for analyzing RNA structure in biologically important RNA-protein
complexes (RNPs). If a protein binds to a simple, single-stranded element, SHAPE can
identify the precise binding site directly. Conversely, protein binding can promote large-
scale structural rearrangement and thereby change SHAPE reactivity in many regions of an
RNA.
As an example of detection of direct binding, we studied packaging of the retrovirus, MuLV.
Retroviruses have evolved conserved pathways to recognize genomic RNA dimers and to
specifically exclude monomeric genomes and cellular RNAs. Packaging of RNA genomes
into nascent virions is mediated by interactions with the nucleocapsid domain of the Gag
protein. SHAPE reagents readily penetrate viral particles and were used to detect differences
between protein-bound RNA inside virions and protein-free RNA that had been gently
extracted from virions15,38. In addition, protein-RNA interactions were probed inside viral
particle in reverse-footprinting experiments in which nucleocapsid-RNA interactions were
weakened by treatment with a reagent that disrupted the fold of the nucleocapsid domain.
SHAPE analysis indicated that the nucleocapsid domain of Gag binds and constrains the
first and last nucleotides within a tandemly repeated UCUG motif (in blue, Figure 8A),
flanked by base paired regions (Figure 8B)38. This work demonstrates the ability of SHAPE
to precisely detect protein-RNA interactions at single-nucleotide resolution, to reveal the
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overall architecture of a binding site, and to do so in a complex virus particle environment.
Analogous studies identified key components of the packaging signal for HIV-115.
Protein-facilitated folding of the bI3 group I intron ribozyme illustrates the ability of
SHAPE to visualize large-scale, protein-induced conformational changes in RNA21,49. To
achieve its enzymatically active splicing conformation, the bI3 intron binds one copy of a
maturase protein and two copies of the Mrs1 protein50,51. SHAPE analysis of the free bI3
RNA revealed that much of the RNA forms base pairs that are not consistent with the active
conformation (see green-black and yellow-gray helices, Figure 8C)52. The complex
alternative secondary for the free RNA could be specifically tested by the SHAPE-analysis-
of-point-mutations approach42,52, which readily detects long-range RNA interactions
mediated by structures separated by hundreds of nucleotides. SHAPE and hydroxyl radical
probing were then used to identify the binding sites for the bI3 maturase and Mrs1 proteins
and to determine the complex RNA structural rearrangements induced by each protein21,49.
Strikingly, protein binding induced large-scale structural rearrangements in the RNA that
ultimately stabilized specific long-distance tertiary interactions (Figure 8C, red and blue
arrows). Protein-mediated stabilization of tertiary interactions appears to pull the secondary
structure into an energetically disfavored, but functional conformation (Figure 8D)49,53.
Experimental Frontiers in RNA Structure Analysis
It is likely that RNA structure governs numerous elements of gene expression. However,
until recently, it was not possible to obtain an experimentally-based understanding of the
relationship between RNA structure and gene function on a global scale. This general
problem is by no means solved, but a number of groups have begun to explore hypotheses
based on structural information collected on RNA genomes or transcriptomes4,54,55. SHAPE
was recently used to probe the structure of 99% of the 9,173 nucleotides in the genome of
the NL4-3 strain of HIV-14, providing the first data-guided model for the structure of an
entire RNA genome. When data collected on the HIV-1 genome were smoothed over a 75-
nucleotide window, we observed that regions known to be functionally important –
including elements in the 5′ region of the genome, at the frameshift element that allows
translation of Pol, and at the Rev responsive element (RRE) – tended to have low SHAPE
reactivities and were thus highly structured4. The SHAPE analysis also showed that there
were numerous additional highly structured regions that had not previously been associated
with a biological role.
Intriguingly, there is a strong correlation between RNA structure and the domain structure of
the encoded protein4. HIV-1 genome regions with low SHAPE reactivities correspond to
loops between domains in the encoded protein (Figure 9). This observation is consistent
with the hypothesis that RNA structure regulates the rate of ribosome processivity to
facilitate protein folding. This model is supported by ribosome mapping experiments that
show that pausing occurs preferentially in regions of high levels of RNA structure4 and with
a study that found that yeast mRNAs tend to have a greater degree of RNA structure within
their coding sequences than in their untranslated regions54.
Genome-wide SHAPE data was also used to generate a working model for the secondary
structure of an entire authentic HIV-1 genome. This model includes proposals for new
regulatory motifs in the genome, including the ribosome frameshifting element (Figure 6B),
for structures that comprise protein domain junctions, for a domain that encodes the signal
peptide in the Env protein, and for regions that have a conserved lack of structure, including
both hypervariable sequences in Env and splice site acceptors4. Subsequent independent
work has found that there is a strong correlation between HIV-1 RNA genome structure and
recombination56.
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The first analysis of an entire RNA genome revealed that the HIV-1 genomic RNA is
densely populated with highly structured regions, many of which have clearly identifiable
functional roles in HIV-1 replication4. Moreover, it has become possible to predict RNA
structures on the kilobase scale with good accuracy27. The extent of structure in intact RNAs
appears to be pervasive, to correlate extensively with key elements of gene expression, and
to plausibly constitute a second level of the genetic code. The available information suggests
that we have just scratched the surface regarding how biological information is encoded in
the structure of RNA.
The ability of SHAPE to probe the local nucleotide environment of RNA inside viral
membranes15,38, opens the door to new and exciting experiments. There appear to be no
significant limitations to using SHAPE in even more complex environments, including cells.
RNA modification by SHAPE reagents leaves stable adducts that capture an imprint of the
RNA structure during the short time the reagents are active. Subsequent purification of the
RNA does not obscure this imprint and SHAPE is likely to prove broadly useful for
exploring numerous structural states of RNA in vivo.
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Figure 1. The RNA 2′-hydroxyl group and SHAPE chemistry
(A) Position of the 2′-hydroxyl group. (B) Mechanism of the SHAPE reaction to form 2′-O-
adducts at flexible nucleotides. (C) Mechanism of the parallel hydrolysis reaction.
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Figure 2. Overview of the SHAPE Experiment
(A) RNA is selectively modified (red dots) at flexible nucleotides in an RNA. (B) Positions
of adduct formation are detected by primer extension. (C) Primer extension products from
the experimental, no-reagent control, and sequencing markers are resolved by capillary
electrophoresis. (D) Electropherograms are computationally deconvoluted to yield
normalized SHAPE reactivities(see scale). (E) Superposition of SHAPE reactivities on a
secondary structure model for the TPP riboswitch aptamer domain16.
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Figure 3. SHAPE reactivities are independent of nucleotide identity and correlate quantitatively
with local nucleotide flexibility
(A) Intrinsic nucleotide-specific reactivities for NMIA and 1M717. (B) Correlation between
the model-free generalized order parameter, S2, and SHAPE reactivity in the U1A-binding
RNA element20 Low, medium, and high SHAPE reactivities are emphasized in black,
yellow and red, respectively.
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Figure 4. Comparison of RNA secondary structure predictions for the 5′ domain of E. coli 16S
rRNA
Using (A) no experimental constraints, (B) conventional chemical probing reagents, or (C)
SHAPE reactivity-based pseudo free energy change terms (ΔGSHAPE) as constraints27. Base
pairs in the accepted structure that are missing in the prediction (×) and base pairs that are
predicted incorrectly (green and blue lines) are indicated. Green boxes and dots indicate
areas in the co-variation structure where SHAPE reactivities support formation of alternate
base pairs.
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Figure 5. SHAPE reactivities support revised RNA secondary structure models
(A) Original model for the HIV-1 frameshift element31 and (B) revised model based on S
HAPE data4. (C) Initial model for the viral dimerization and packaging domain of MuLV34
and (D) SHAPE-supported model37. Red bars and asterisks highlight areas where the
SHAPE data are not consistent with a secondary structure model. Notable functional
elements in the SHAPE-supported structures are highlighted by blue boxes.
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Figure 6. Analysis of complex RNA structural transitions by SHAPE
Structural changes in tRNAAsp induced by varying the Mg 2+concentration, upon heating
(Δ), or upon binding by tobramycin are shown39,40.
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Figure 7. Measuring RNA dynamics by SHAPE
(A) Use of fast (1M7) and slow (IA) reagents to detect nucleotides with slow conformational
dynamics43. (B) Structural context of A130, which exhibits slow dynamics and functions as
a molecular timer for folding of an RNase P specificity domain44. (C) Time-resolved
SHAPE reactivities and (D) representative time–progress curves. (E) Model for time-
resolved tertiary folding of the B. subtillis RNase P specificity domain12. Nucleotides that
fold in the fast verses slow phase are emphasized in red and blue, respectively, in panels C–
E.
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Figure 8. SHAPE analysis of RNA-protein interactions
(A) Binding of nucleocapsid to the MuLV genomic RNA results in protection of a small
number of nucleotides from SHAPE modification. (B) Model for the nucleocapsid RNA
binding site. Nucleotides most strongly protected are emphasized in blue; flanking helices
are shown as cylinders38. (C) The bI3 group I intron RNA exists in a mis- and unfolded state
prior to protein binding52. (D) Binding by the maturase and Mrs1 proteins stabilize long-
range tertiary interactions (blue and red arrows) and induce widespread structural
rearrangements as shown by changes in SHAPE reactivities21,49.
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Figure 9. SHAPE reveals a relationship between RNA structure and protein domain structure in
the HIV-1 genomic RNA
(A) Organization of the HIV-1 genome, emphasizing the Gag coding region. (B) Median
SHAPE reactivities over a moving 75 nucleotide window. (C) Relationship between
structured RNA regions and the peptide loops that link independent protein domains in
Gag4.
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A toolbox of useful SHAPE reagents.
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